A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis due to NASH/MASH.
Epistemonikos ID: 65689fdf1d722111f8e1a0374dbb827d5950ea5b
First added on: Aug 01, 2024